Global Milk Allergy Clinical Trials Review market was valued at USD 987 million in 2024 and is projected to reach USD 1.21 billion by 2032, exhibiting a CAGR of 3.0% during the forecast period. This growth is driven by increasing awareness and prevalence of cow’s milk allergy (CMA), which affects approximately 2-3% of infants and young children globally, according to epidemiological studies. https://www.24lifesciences.com/download-sample/2056/milk-allergy-clinical-trials-review-market-market